Clinical Trial Update: Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of chidamide in combination with cisplatin for head and neck adenoid cystic carcinoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma of the Head and Neck

Drugs mentioned

• CISPLATIN (cisplatin)
• Chidamide (chidamide)

Snippet

Sponsor: Fudan University | Conditions: Adenoid Cystic Carcinomas, Cisplatin | Phase 2 | Status: COMPLETED